Market research
VLS.AU Vita Life Sciences Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 149M
- P/E ratio
- 13.8
- Analyst target
- 0.85
- Dividend yield
- 5.2%
- Beta
- 0.48
Community
Investor discussion
1 comment
Sign in to join the VLS.AU discussion.
5 years, 5 months ago
Vita Life Sciences Limited is currently in a long term uptrend where the price is trading 10.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Vita Life Sciences Limited's total revenue rose by 10.8% to $24M since the same quarter in the previous year.
Its net income has increased by 51.6% to $3M since the same quarter in the previous year.
Finally, its free cash flow grew by 24.5% to $1M since the same quarter in the previous year.
Based on the above factors, Vita Life Sciences Limited gets an overall score of 5/5.